Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot.
In a statement issued Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data.”
AstraZeneca didn't reveal any information about the possible side effect except to call it “a potentially unexplained illness.” The health news site STAT first reported the pause in testing, saying the possible side effect occurred in the United Kingdom.
An AstraZeneca spokesperson confirmed the pause in vaccinations covers studies in the U.S. and other countries.
Late last month, AstraZeneca began recruiting 30,000 people in the U.S. for its largest study of the vaccine.
It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain, and in smaller studies in Brazil and South Africa.
Two other vaccines are in huge, final-stage tests in the United States, one made by Moderna Inc. and the other by Pfizer and Germany's BioNTech.
Those two vaccines work differently than AstraZeneca's, and the studies already have recruited about two-thirds of the needed volunteers.
Temporary holds of large medical studies aren't unusual, and investigating any serious or unexpected reaction is a mandatory part of safety testing.
AstraZeneca pointed out that it's possible the problem could be a coincidence; illnesses of all sorts could arise in studies of thousands of people.
“We are working to expedite the review of the single event to minimize any potential impact on the trial timeline,” the company statement said.
It’s likely the unexplained illness was serious enough to require hospitalization and not a mild side effect such as fever or muscle pain, said Deborah Fuller, a University of Washington researcher who is working on a different COVID-19 vaccine that has not yet started human testing.
“This is not something to be alarmed about,” Fuller said.
Instead, it’s reassuring that the company is pausing the study to figure out what’s happening and carefully monitoring the health of study participants.
Dr. Ashish Jha of Brown University said via Twitter that the significance of the interruption was unclear but that he was “still optimistic” that an effective vaccine will be found in the coming months.
“But optimism isn’t evidence,” he wrote. “Let’s let science drive this process.”
Angela Rasmussen, a virologist at Columbia University in New York, tweeted that the illness may be unrelated to the vaccine, "but the important part is that this is why we do trials before rolling out a vaccine to the general public.”
During the third and final stage of testing, researchers look for any signs of possible side effects that may have gone undetected in earlier patient research.
Because of their large size, the studies are considered the most important study phase for picking up less common side effects and establishing safety.
The trials also assess effectiveness by tracking who gets sick and who doesn’t between patients getting the vaccine and those receiving a dummy shot.
The development came the same day that AstraZeneca and eight other drugmakers issued an unusual pledge, vowing to uphold the highest ethical and scientific standards in developing their vaccines.
The announcement follows worries that President Donald Trump will pressure the U.S. Food and Drug Administration to approve a vaccine before it’s proven to be safe and effective.
The U.S. has invested billions of dollars in efforts to quickly develop multiple vaccines against COVID-19.
But public fears that a vaccine is unsafe or ineffective could be disastrous, derailing the effort to vaccinate millions of Americans.
Representatives for the FDA did not immediately respond to requests for comment Tuesday evening.
AstraZeneca’s U.S.-traded shares fell more than 6% in after-hours trading following reports of the trial being paused.
AP Newsroom
Wed Sep 09 2020
AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. The company said the study will involve up to 30,000 adults from various racial, ethnic and geographic groups. AP file pic
Brazil's Lula says head injury 'serious,' with update from doctors in coming days
The president's injury forced him to cancel a trip to Russia for a summit of the BRICS group of major emerging markets being held in Kazan.
Blinken heads to Israel to revive Gaza ceasefire talks after Sinwar death
Blinken will focus discussions on how to end the war, plans for the enclave after the fighting ends and how to improve humanitarian assistance.
Facebook owner Meta restarts facial recognition tech in 'celeb-bait' crackdown
Meta said it will enroll about 50,000 public figures in a trial which involves automatically comparing their Facebook profile photos with images used in suspected scam advertisements.
BHP trying to avoid responsibility over Brazilian dam collapse, UK court told
More than 600,000 Brazilians, 46 local governments and around 2,000 businesses are suing BHP over the 2015 collapse of the Mariana dam in southeastern Brazil.
Minimum wage not benchmark for all employees' starting salaries - Sim
Steven Sim says the increase in the minimum wage is intended as a basic wage for workers with lower academic qualifications and skills.
Climate and China weigh on how the US views Pacific relations
Pacific leaders keep their preference for US President quiet, yet viewing relations only through the lens of China does nobody a service.
Gulen, the powerful cleric accused of orchestrating a Turkish coup, dies
Gulen was a one-time ally of Erdogan but they fell out spectacularly, and Erdogan held him responsible for the 2016 attempted coup.
[COLUMNIST] The reality of earthquakes in Malaysia: A threat we can’t ignore
The government needs to prepare the public to deal with such disasters in any way possible.
'PROTEGE-Veteran' provides job assurance for retirees
This is an aggressive step by the government to protect the welfare of retirees, said Dr Mohd Hasril Amiruddin.
US says THAAD anti-missile system is 'in place' in Israel
THAAD is a critical part of the US military's layered air defense systems and adds to Israel's already formidable anti-missile defenses.
IMAN Research calls for strengthening human security in 2025 Budget
IMAN Research identifies key areas for enhancement within the Malaysian government's Third MADANI Budget 2025.
Zambry assures academics of freedom of speech
Zambry says he is committed to preventing any actions that could infringe upon the rights and freedoms of academics across universities.
Media licensing framework development involves multiple consultations - Teo
Teo Nie Ching says the views of stakeholders have been considered through several engagement sessions and ongoing consultations.
ANALYSIS - World lags on 2030 nature goals headed into UN COP16 talks
A top concern for countries and companies is how to pay for conservation, with the COP16 talks aiming to develop new initiatives.
Situation in South China Sea safe, under control - Adly
Adly Zahari clarifies that reports of Chinese maritime assets near country's border mainly involve its Coast Guard, not its naval warships.
MOHE sets agenda to boost higher education cooperation ahead of ASEAN Chairmanship 2025
Datuk Seri Dr. Zambry said all higher education institutions must be involved to successfully implement the ASEAN chairmanship agenda.
King receives credentials of 12 foreign envoys to Malaysia
His Majesty Sultan Ibrahim welcomes nine new foreign envoys and appoints two Malaysian diplomats in a ceremony at Istana Negara.
Israel gives the US its demands for ending war in Lebanon, Axios reports
Israel demands IDF "active enforcement" to prevent Hezbollah from rearming and rebuilding military infrastructure near the border.
Indonesia's Prabowo swears in cabinet of over 100 ministers, deputies
Prabowo Subianto's cabinet has 48 ministries with over 100 ministers and deputies, including two re-appointments.
Freeze on foreign worker employment quota to continue - Saifuddin
Datuk Seri Saifuddin Nasution Ismail said as of Sept 15 the total number of foreign workers is nearing the stipulated ceiling.